Gleneagle Gold announced its intention to exit the resources sector through the back door today, with a proposal to buy a Melbourne-based unlisted biotechnology company for a share package worth $2 million.
Gleneagle to buy biotech firm for $2m
16/03/2015 - 13:08
Data & Insights
Related Articles
05 Mar 2024
Peppermint raises $1.1m amid loss
25 Jul 2023
Board Moves July 25, 2023
14 Feb 2023
Cunningham exits CPS
22 Dec 2022
Perth broker sues over ‘defamatory’ publication
09 Dec 2022
Patriot Lithium makes ASX debut
10 Feb 2022
Allup Silica pursues ASX listing
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX